We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRT
13526
PUT
DELISTED
Assertio
ASRT
$22K ﹤0.01%
1,653
+306
+23% +$5.24K
NINE
13527
DELISTED
Nine Energy Service
NINE
$22K ﹤0.01%
11,997
-78,158
-87% -$175K
TC
13528
TuanChe
TC
$57.3M
$22K ﹤0.01%
+34
New +$25.9K
VSA
13529
VisionSys AI
VSA
$9.27M
$22K ﹤0.01%
+6
New +$27.7K
REED
13530
DELISTED
Reeds, Inc. Common Stock
REED
$22K ﹤0.01%
720
-686
-49% -$25.6K
PTPI
13531
DELISTED
Petros Pharmaceuticals
PTPI
$21K ﹤0.01%
41
-99
-71% -$64.4K
GHSI
13532
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$21K ﹤0.01%
339
-165
-33% -$11K
TOVX icon
13533
Theriva Biologics
TOVX
$10.5M
$20K ﹤0.01%
175
+133
+317% +$16.5K
NH
13534
CALL
DELISTED
NantHealth, Inc
NH
$20K ﹤0.01%
827
-40
-5% -$1.2K
SECO
13535
PUT
DELISTED
Secoo Holding Limited ADR
SECO
$20K ﹤0.01%
1,610
-2,030
-56% -$37.4K
GNCA
13536
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$20K ﹤0.01%
10,500
-13,600
-56% -$26.7K
LGHL
13537
CALL
Lion Group Holding
LGHL
$729K
0
PXS icon
13538
Pyxis Tankers
PXS
$52.8M
$19K ﹤0.01%
+6,319
New +$18.9K
RGLS
13539
PUT
DELISTED
Regulus Therapeutics
RGLS
$19K ﹤0.01%
2,790
-3,270
-54% -$24K
YQ
13540
CALL
17 Education & Technology Group
YQ
$22.6M
$19K ﹤0.01%
+1,055
New +$31.4K
TWLVW
13541
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$19K ﹤0.01%
+29,431
New +$21.5K
MOTS
13542
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$19K ﹤0.01%
93
-62
-40% -$15.7K
MDAIW icon
13543
Spectral AI Warrants
MDAIW
$5.84M
$18K ﹤0.01%
32,789
TOMZ icon
13544
TOMI Environmental Solutions
TOMZ
$13.5M
$18K ﹤0.01%
4,293
-652
-13% -$4.22K
XIN
13545
DELISTED
Xinyuan Real Estate
XIN
$18K ﹤0.01%
1,009
-5,034
-83% -$105K
TBLT
13546
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$18K ﹤0.01%
4
+1
+33% +$5.84K
RIBT
13547
DELISTED
RiceBran Technologies
RIBT
$18K ﹤0.01%
2,976
-107
-3% -$907
AIHS icon
13548
Senmiao Technology Ltd
AIHS
$23.9M
$17K ﹤0.01%
292
-147
-33% -$10.2K
IMNN icon
13549
CALL
Imunon
IMNN
$6.93M
$17K ﹤0.01%
95
-157
-62% -$32.6K
SABSW icon
13550
SAB Biotherapeutics Warrant
SABSW
$193K
$17K ﹤0.01%
18,875

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.